Filing Details
- Accession Number:
- 0001179110-16-027939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-27 16:43:46
- Reporting Period:
- 2016-07-26
- Filing Date:
- 2016-07-27
- Accepted Time:
- 2016-07-27 16:43:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1452290 | J Michael Warmuth | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2016-07-26 | 26,800 | $25.25 | 81,811 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2016-07-26 | 11,951 | $43.48 | 69,860 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2016-07-26 | 10,349 | $43.49 | 59,511 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2016-07-26 | 4,500 | $43.50 | 55,011 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2016-07-26 | 26,800 | $0.00 | 26,800 | $25.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-16 | 2017-02-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares Without Par Value | 29,586 | Indirect | By trust |
Footnotes
- Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
